Promega supports scale up
of COVID-19 testing capacity
In a major step to counter the coronavirus crisis, Promega India is supporting
government agencies through its automated instruments. The Maxwell® RSC
instrument is a compact, automated RNA extraction platform that processes
up to 48 samples of Corona Virus simultaneously in less than 35 minutes .
The automated Promega solution allows laboratories to process up to 400
samples in a typical 8-hour shift
As Covid19 cases accelerate, the country has Forensic Science Laboratory-Jaipur and SMS Hospital Jaipur join hands
decided to use scale up testing capacity to together to use Promega Maxwell® RSC 48 to increase COVID-19 testing
100,000 tests per day in the coming days capacity. COVID-19 pandemic situation labs are experiencing unprecedented
need for reagents to perform viral testing. This urgency has led many
scientists & communities to make new connections and build creative,
collaborative solutions.perform viral testing.
Forensic Science Laboratory-Jaipur has recently procured two Maxwell® RSC 48 instruments from Promega for extracting
DNA from casework samples . The government firm has now decided to support SMS Hospital Jaipur in this pandemic
situation by providing the procured instruments to the renowned hospital for RNA extraction for Corona Virus testing.
The Promega team supported with its Maxwell unit at AIIMS Rishikesh .The team also conducted the virtual training so the
labs can use the instrument in this pandemic situation.
Promega also offered a Maxwell unit at Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)
Mumbai for emergency use. Mumbai has the highest number of confirmed COVID-19 cases in India so far.
Promega Maxwell units are also used by few other labs across the India as for COVID testing .
“We are grateful that leading communities across the globe are supporting each other during this COVID-19 pandemic
and that Promega products can be of use to combat against the difficult times the world is facing. Promega began
scaling up reagent manufacturing in January to address global needs and has maintained accelerated production since
then. Operations teams continue to work on ways to expand production to further meet unprecedented demand,” said Dr
Rajnish Bharti, General Manager Promega Biotech India Pvt Ltd.
Promega manufactures reagents used for COVID-19 testing. The company’s components currently support approximately
28 COVID-19 test kits around the world, and Promega provides RNA extraction reagents for more than 500 clinical labs
globally.
Promega remains committed to supporting scientists around the world during the COVID-19 pandemic.
Promega Biotech India Private Limited : Unit No S -114, Salcon Aurum Building Jasola District Centre, New Delhi-110044
Questions? Contact us at [email protected]
RNI No. DELENG/2004/13061 Published on 28th of previous month PCW/193/2020-2022
Posting Date: 30th of every month Posted at Ex Servicemen Colony PO, Pune-38
Why Choose
Corning Fetal
Bovine Serum?
Corning high-quality
fetal bovine serum
products complement
our wide range of
sterile, low endotoxin
classical cell culture
media perfectly.
Origin Statement
We offer several premium FBS (Fetal Bovine Serum) products collected in approved abattoirs from herds in the
United States. Also, our regular FBS (Fetal Bovine Serum) is collected in approved facilities from herds located in
countries approved by the USDA for importation into the United States. In certain regions we also provide South
America-sourced FBS (Fetal Bovine Serum) manufactured at facilities approved by the appropriate local authorities.
Sera Processing ISIA Traceability Certified
Corning Life Sciences has been traceability
certified according to the International Serum
Industry Association (ISIA) Traceability Program.
EDQM Certificates of Suitability
Fetal Bovine Serum, United States Origin
This product has been granted a Certificate of
Suitability, R0-CEP 2018-271, by the European
Directorate for the Quality of Medicines
(EDQM) certifying that the product meets the
criteria described in the current version of the
monograph no. 1483 of the European
Pharmacopoeia “Product with risk of
transmitting agent of animal spongiform
encephalopathies.”
Stay tuned for more update about our
FBS offering!
India [email protected]
t 91 124 4604000
f 91 124 4604099
The words you are searching are inside this book. To get more targeted content, please make full-text search by clicking here.
REGULATE MEDICAL AESTHETICS The market that is worth billions of dollars in India has witnessed significant growth in the demand for aestheticprocedures owing to the rise in the number of doctors and surgeons providing effective medical aesthetictreatments and the launch of technologically advanced products for the same. However, India lacks proper guidelines to regulate the use of specific products and procedures for aesthetic treatment.
Discover the best professional documents and content resources in AnyFlip Document Base.
Search